/ /

  • linkedin
  • Increase Font
  • Sharebar

    Multicenter study supports efficacy of novel gel stent in refractory glaucoma


    Review of surgical technique

    Dr. Sheybani also reviewed the surgical technique for implantation of the stent, which is done using a preloaded injector. Per FDA requirement and in contrast to other studies of the device, the procedure was performed with subconjunctival mitomycin-C pre-treatment. The ideal position for the stent is about 2 mm in the subconjunctival space, 3 mm in the sclera, and 1 mm in the anterior chamber, Dr. Sheybani said.

    Patients in the study are being followed to 18 months for safety evaluation.

    Dr. Sheybani is a consultant to Allergan.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results